University of Minnesota. Driven to Discover.
Of 10 million people estimated to have TB in 2018, 7 million were diagnosed, meeting a recent UN goal.
"India and China are by far the biggest hot spots of antimicrobial resistance in animals."
The shorter, simpler regimen with the new drug is poised to improve treatment against a difficult disease and to lower costs.
The WHO is stepping up its response in Europe, as cases surge in Tunisa and researchers plot at-risk US sites.
In 17 nations, most notably China and India, broader-spectrum drugs are more widely used.
Alongside the finding that progress has stalled in hard-hit countries, the WHO and partners launch a new response strategy.
Almost a third of TB cases in India are multidrug-resistant, and rates are climbing in Chinese kids.
New paper argues that a combination of caps, user fees, and limits on meat consumption could cut antibiotic use in food animals by 80%.
In addition to widespread H5N8, H5N1 is confirmed in Nigeria and H5N6 in Japan.
Meanwhile, many countries across Europe and Asia continue to battle outbreaks of several strains.
Sort Results By:
Get CIDRAP news and other free newsletters.
Sign up now»
Unrestricted financial support provided by
Grant support for ASP provided by
Become an underwriter»
CIDRAP - Center for Infectious Disease Research and PolicyOffice of the Vice President for Research, University of Minnesota, Minneapolis, MN
© 2019 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.